Influenza Vaccines for the World

6-9 October 2015, Sao Rafael Atlantic Hotel, Albufeira, Algarve, Portugal

  • Increase font size
  • Default font size
  • Decrease font size

Introduction

Influenza Vaccines for the World – IVW 2015 is the fifth international conference and exhibition in this important series of influenza vaccine meetings. The IVW conference series focuses on ‘Influenza Vaccination Issues’ and is designed to complement the other two major influenza meetings in the conference calendar: ESWI and the Options for Control of Influenza.

The IVW series is an international forum for world renowned experts in the field of influenza vaccines and related issues (adjuvants/delivery/vaccination strategies) to report on the latest data and trends associated with current and new influenza vaccines/technologies and their availability/delivery/implementation worldwide.

The IVW 2015 Scientific Advisory Panel invites the influenza community worldwide to submit Late-Breaking abstracts for consideration for inclusion in the IVW 2015 Final Oral & Poster Scientific Programmes.

Scientific Advisory Panel

Othmar Engelhardt (NIBSC/HPA, Potters Bar, UK)
Eric Desauziers (Sanofi-Pasteur, Lyon, France)
John Oxford (Queen Mary College London / hVIVO Ltd / Oxford Media & Medicine, London, UK)
Albert Osterhaus (University of Veterinary Medicine Hannover, Hannover, Germany)
Ted Ross (University of Georgia, Athens, Georgia, USA)
Yoshihiro Kawaoka (University of Wisconsin, Madison, Wisconsin, USA)
Helen Bright (MedImmune, Liverpool, UK)
Jonathan Van Tam (University of Nottingham, UK)
Rob Lambkin-Williams (hVIVO Ltd., London, UK)
Dirk Poelaert (GSK Vaccines, Wavre, Belgium)
Ronald Kompier (FluConsult, Noordwijk, The Netherlands)
Keiji Fukuda (WHO, Geneva, Switzerland)
Manon Cox (Protein Sciences Corporation, Meriden, Connecticut, USA)
Emanuele Montomoli (VisMederi Srl, Siena, Italy)
Yotam Levin (NanoPass Technologies Ltd, Rehovot, Israel)
Manmohan Singh (Novartis Influenza Vaccines, Holly Springs, North Carolina, USA)
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)
Edward Remarque (BPRC, Rijswijk, The Netherlands)

Conference Scope

IVW 2015 will address the following important topics:

  • Surveillance Issues / Burden of Disease
  • Immunological Issues
  • Social / Political / Financial Issues Surrounding Influenza Vaccination
  • Novel Developments
  • Production / Formulation Issues / Manufacturing Issues
  • Vaccine Usage / Targeting Strategies
  • Influenza Vaccines / Adjuvants – Improvement Issues
  • Pandemic Preparedness Issues / Licensing Issues

Call For Latebreaking Oral and Poster Abstracts

Latebreaker abstracts for oral and poster presentation are called for. Please submit your abstract for either oral or poster presentation to John Herriot, IVW 2015 Organizer by Wednesday 9th September 2015.

 

IVW 2015 Delegates

Login details will be supplied after you have registered for the event.


IVW 2015 Sponsors

  • VaxArt
  • Inovio
  • Nanopass
  • GlaxoSmithKline Biologicals
  • Protein Sciences
  • hVIVO
  • FluConsult
  • VisMederi Life Sciences
  • InDevR
  • Fraunhofer USA
  • Novavax
  • Medicago
  • Eurocine Vaccines

IVW 2015 Downloads

IVW 2015 Leaflet

IVW 2015 Mailing List

Name
E-mail Address
What is 3+2-1?